Sentinel node biopsy in Low- and Intermediae endometrial cancer Management: The SLIM-study

Phase 3

Recruiting

• Conditions: cancer of the uterus; endometrial cancer; 10038594; 10029903

• Registration Number: NL-OMON41827
• Lead Sponsor: niversitair Medisch Centrum Sint Radboud

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 28 February 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 142

Inclusion Criteria

low-risk endometrial cancer: type 1 endometrial cancer, stage 1A grade 1 or 2
Intermediate-risk endometrial cancer: type 1 endometrial cancer, stage 1B grade 1 or 2

Exclusion Criteria

- high-risk endometrial cancer: type 2 endometrial cancer, endometrial cancer, 2 or higher or endometrial cancer type 1 stage 1B grade 2 or 3
- intermediate-risk endometrial cancer stage 1A grade 3
- women unfit for surgery
- women unfit for scintigram

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>- the presence of micro- and macro metastasis<br /><br><br /><br>- to examine in how many cases SLN biopsy provides results that change adjuvant<br /><br>treatment</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>- disease free survival data<br /><br><br /><br>- Quality of Life data</p><br>